Immune to Cancer: The CRI Blog
-
Cancer Immunotherapy: The Year in Review and a Look at the Year Ahead
Dr. Elizabeth Jaffee highlights 2018’s advances and 2019’s potential breakthroughs in cancer treatment
-
Dr. James P. Allison, CRI Scientific Director, Awarded 2018 Nobel Prize along with Dr. Tasuku Honjo
Dr. Allison’s discoveries and determination led to the development of the first FDA-approved checkpoint immunotherapy
-
30 Days of CRI Impact
Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.
-
AACR18 Update: Lloyd J. Old Award, Overcoming Immunotherapy Resistance, and the Importance of Dendritic Cells
Day 4 at AACR18 was a special day for CRI’s Dr. Antoni Ribas, and highlighted his and…
-
CRI Researcher Highlights New Technique to Aid Immunotherapy
Dr. Mohammad Rashidian’s nanobodies could help improve doctors’ decisions regarding immunotherapy.
-
Recapping Our 5th Annual Cancer Immunotherapy Month
The 5th Annual Cancer Immunotherapy Month generated more than 6,000,000 impressions and raised over $500,000.
-
NY-ESO-1 Identified as a Promising Vaccine Target in Ovarian Cancer Patients
New study reveals effectiveness of immunotherapy vaccine against aggressive ovarian tumors.
-
2016: The Year of Cancer Immunotherapy
New immunotherapy approvals, “Advance of the Year” recognition, and the partnerships of the future.